HIGHLIGHTS
- who: Masahiro Kagabu and colleagues from the Department of Obstetrics and Gynecology, School of Medicine, Iwate Medical University, Shiwa, Iwate, Japan have published the paper: Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor, in the Journal: (JOURNAL)
- what: The authors report the results of oncolytic HSV therapy with anti-PD-L1 Ab for cervical cancer. The authors demonstrated an increase in tumor-infiltrating CTLs in the T-01 monotherapy and anti-PD-1 Ab combination therapy groups . The authors examined the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.